[HTML][HTML] Real-world data on the diagnosis, treatment, and management of hepatocellular carcinoma in the Asia-Pacific: the INSIGHT study
YK Sim, MC Chong, M Gandhi, YM Pokharkar, Y Zhu… - Liver Cancer, 2024 - karger.com
Introduction: Hepatocellular carcinoma (HCC) is the sixth most commonly diagnosed cancer
and the third leading cause of cancer death worldwide. While there has been rapid evolution …
and the third leading cause of cancer death worldwide. While there has been rapid evolution …
[HTML][HTML] Non-invasive prediction of post-sustained virological response hepatocellular carcinoma in hepatitis C virus: A systematic review and meta-analysis
HA Lee, MN Kim, HA Lee, M Choi… - Clinical and …, 2024 - pmc.ncbi.nlm.nih.gov
Background/Aims Despite advances in antiviral therapy for hepatitis C virus (HCV) infection,
hepatocellular carcinoma (HCC) still develops even after sustained viral response (SVR) in …
hepatocellular carcinoma (HCC) still develops even after sustained viral response (SVR) in …
[PDF][PDF] Non-invasive prediction of post-sustained virological response HCC in HCV: A systematic review and meta-analysis
HA Lee, MN Kim, HA Lee, M Choi… - Clinical and …, 2024 - pdfs.semanticscholar.org
Background: Despite advances in antiviral therapy for hepatitis C virus (HCV) infection,
hepatocellular carcinoma (HCC) still develops even after sustained viral response (SVR) in …
hepatocellular carcinoma (HCC) still develops even after sustained viral response (SVR) in …
Treatment patterns for hepatocellular carcinoma in patients with Child–Pugh class B and their impact on survival: A Korean nationwide registry study
D Jeon, GW Song, HC Lee, JH Shim - Liver International, 2022 - Wiley Online Library
Abstract Background and Aims There are no established practice guidelines for treating
hepatocellular carcinoma (HCC) in patients with Child–Turcotte–Pugh (CTP) class B liver …
hepatocellular carcinoma (HCC) in patients with Child–Turcotte–Pugh (CTP) class B liver …
Comparative Analysis of Atezolizumab Plus Bevacizumab and Hepatic Artery Infusion Chemotherapy in Unresectable Hepatocellular Carcinoma: A Multicenter …
JH Kim, HC Nam, CW Kim, HS Cho, JS Yoo, JW Han… - Cancers, 2023 - mdpi.com
Simple Summary We aimed to compare the prognosis of patients with advanced
hepatocellular carcinoma treated with the first-line atezolizumab plus bevacizumab (AB) …
hepatocellular carcinoma treated with the first-line atezolizumab plus bevacizumab (AB) …
A nationwide study on the current treatment status and natural prognosis of hepatocellular carcinoma in elderly
JJ Yoo, J Lee, GH Choi, MW Lee, DA Park - Scientific Reports, 2023 - nature.com
The aim of this study was to identify the treatment status and natural prognosis of
hepatocellular carcinoma (HCC) patients aged 65 years or older in Korea. We analyzed …
hepatocellular carcinoma (HCC) patients aged 65 years or older in Korea. We analyzed …
[HTML][HTML] Cause of death and cause-specific mortality for primary liver cancer in South Korea: A nationwide population-based study in hepatitis B virus-endemic area
BH Kim, D Lee, KW Jung, YJ Won… - Clinical and molecular …, 2022 - ncbi.nlm.nih.gov
Methods The causes of death and cause-specific mortality risks in patients with primary liver
cancer, diagnosed during 2000–2016, were investigated using the nationwide population …
cancer, diagnosed during 2000–2016, were investigated using the nationwide population …
[HTML][HTML] Concurrent nivolumab and external beam radiation therapy for hepatocellular carcinoma with macrovascular invasion: A phase II study
Background and Aims Nivolumab was the first immune checkpoint inhibitor approved for
hepatocellular carcinoma (HCC). External beam radiation therapy (EBRT) is locally effective …
hepatocellular carcinoma (HCC). External beam radiation therapy (EBRT) is locally effective …
[HTML][HTML] Impact of tumor size on hepatectomy outcomes in hepatocellular carcinoma: a nationwide propensity score matching analysis
SK Hong, KW Lee, S Lee… - Annals of Surgical …, 2022 - synapse.koreamed.org
Purpose The aim of this study was to compare surgical outcomes after liver resection for
hepatocellular carcinoma (HCC) according to tumor size using a large, nationwide cancer …
hepatocellular carcinoma (HCC) according to tumor size using a large, nationwide cancer …
Identification of patients with favorable prognosis after resection in intermediate-stage-hepatocellular carcinoma
HA Lee, M Lee, JJ Yoo, HS Chun, Y Park… - … Journal of Surgery, 2024 - journals.lww.com
Methods: This multicenter retrospective study included patients who underwent resection or
trans-arterial chemoembolization (TACE) for intermediate-stage HCC (2008–2019) …
trans-arterial chemoembolization (TACE) for intermediate-stage HCC (2008–2019) …